O2h to Provide Chemistry Support to Chromocell

By O2h, PRNE
Wednesday, June 22, 2011

CAMBRIDGE, England, AHMEDABAD, India and NORTH BRUNSWICK, New Jersey, June 23, 2011 -


Oxygen Healthcare Ltd. (O2h), a Piramal Group
and Chromocell Corporation, an
emerging life sciences company active in both flavors and
therapeutics discovery, today signed an agreement under which O2h
will provide supplemental chemistry support to further accelerate
the drug discovery initiatives at Chromocell.  

“I have known O2h for a number of years and am impressed by its
delivery focus,” said David Palling, Senior Vice President,
Therapeutics, Chromocell. “With the in-house chemistry resources
and the faster-than-expected progress made in our therapeutic
programs, complementary support from O2h will help us maximize
resources and reach our end-points quicker.  I look forward to
this opportunity of working with them to advance our drug discovery

O2h will provide Chromocell during 2011 with focused libraries
of compounds at mg-g scale for various projects.

Sunil Shah, CEO, O2h said “O2h has optimized its operations for
discovery speed and delivery to help accelerate drug discovery
efforts of companies in the United States, Europe and Japan. It is
our privilege to work with the experienced team led by Dr. Palling
at Chromocell,”  

About Chromocell Corporation

Chromocell, founded in 2002 and headquartered in North
Brunswick, N.J.
, is an emerging life sciences company which
improves consumer products and patient lives through breakthrough
science and technologies.  It is focused on the discovery and
development of both flavors and therapeutics through its pioneering
Chromovert ® technology, a process that enables the company to use
naturally occurring systems that mimic human biology as part of its
discovery platform.  Chromocell works with worldwide consumer
goods companies to develop flavor ingredients and sweetness
enhancers.  Its therapeutics program is concentrated on pain
relief, respiratory diseases, and other disorders where Chromovert
technology offers the advantage of addressing complex and
intractable targets. For more information, go to href="www.chromocell.com">www.chromocell.com.

About O2h, a Piramal Group Company

O2h is the discovery services arm of Piramal Pharma Solutions
Ltd, a top 10 global CRAMS group, offering a unique full-service
partnership at every stage of the pharma life-cycle. Piramal Pharma
Solutions employs 2,500 people across 9 specialist sites in North
, UK and India. The Piramal group has a 140 year history and
is publicly listed company (BSE: PIRAMALHE).

O2h’s 200 employees work within its project management office in
Cambridge, UK and its operations in Ahmedabad India. Current
clients of O2h include several top 20 pharmaceutical and
biotechnology companies in the US, Europe and Japan.O2h adheres to
the highest standards of performance with a particular emphasis on
rapid interactive communications and delivery speed. Services
provided by O2h include FTE-based medicinal, synthetic chemistry,
and process chemistry as well as in vitro biology services. Further
information on O2h can be found at href="www.o2h.com">www.o2h.com.


Ekta Ahuja PhD
23, Cambridge Science Park    

Barbara Shear
Chromocell Corporation
685 U.S. Highway One
North Brunswick, NJ 08902


Ekta Ahuja PhD, O2h, 23, Cambridge Science Park , CB4 0EY, info at o2h.com, +44(0)1223437014; Barbara Shear, Chromocell Corporation, 685 U.S. Highway One, North Brunswick, NJ 08902, +1-732-565-1113

will not be displayed